SBIR/STTR Research Award

Efficient Characterization of DNA-Protein Binding using a High-Throughput Sequencer

Award identifier 65fd6dd6cab852acef3e339bc5e01ec5a39383f43ce9aebfc4ba2e2fa1db5da6Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$176,785

Program and phase

SBIR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
APTAMATRIX, INC.
Proposal award date
2016-07-01
Contract end date
2017-12-31
UEI
P6QQJF456L83
Solicitation number
PA14-071
Topic code
400

Research abstract

DESCRIPTION provided by applicant Aptamers are nucleic acid based andquot probeandquot molecules that provide similar affinity and specificity as antibodies towards protein targets Aptamers have found utility in a wide variety of diagnostic and therapeutic applications In AptaMatrix In helped pioneer a new method for discovering aptamer probes called Acyclic Identification of Aptamer AIA that leveraged the sequencing capacity of Illumina high throughput sequencing platforms This Phase I SBIR project is focused on further improving the AIA method by integrating a post sequencing Illumina protein screening step secondary screen into the AIA workflow We have established three project aims to successfully complete this project within the Illumina flowcell test optimize a novel method for generating truncated single stranded DNA ssDNA clusters needed for optimal target protein binding on the sequencing system integrate and optimize established protocols and software needed to image DNA protein binding and validate the complete method by monitoring DNA protein binding affinities using a well characterised thrombin thrombin binding aptamer TBA DNA library system Completion of this project will establish a robust and highly valuable platform for rapid and highly efficient aptamer discovery and assessment In Phase II we plan to scale up this method on our GAiix platform to offer rapid aptamer discovery services and consider purchasing a next generation Illumina sequencing platform to implement protein imaging capabilities to accommodate higher sample throughput at a lower operational cost PUBLIC HEALTH RELEVANCE Aptamers are nucleic acid based andquot probeandquot molecules that provide similar affinity and specificity as antibodies towards protein targets This Phase I SBIR project is directed at improving AptaMatrixandapos s AIA aptamer discovery approach by integrating a post sequencing protein imaging on an Illumina sequencing platform

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

11 SBIR/STTR records share this UEI (2003–2020). Reported award amounts total $6,277,598. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services, Department of Defense, Department of Homeland Security

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.